GAD-7 Anxiety Score Calculator

What the GAD-7 is, and what it is not

The GAD-7 is a 7-item screening questionnaire for generalized anxiety disorder, published in 2006 by Robert Spitzer, Kurt Kroenke, Janet Williams and Bernd Löwe. It’s now the single most-used anxiety screening tool worldwide in primary care, behavioral health, and research settings.

It’s a screening tool, not a diagnostic instrument. A high score signals “worth investigating further”. It does not itself diagnose generalized anxiety disorder. Diagnosis requires a clinical interview with a qualified mental health professional, using DSM-5-TR or ICD-11 criteria.

The full validated reference is: Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.

The 7 questions

Each asks about the past 2 weeks. Rate frequency 0-3:

1. Feeling nervous, anxious, or on edge
2. Not being able to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it is hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful might happen

Scoring scale

Total possible: 0-21.

Severity interpretation

The score of 10 is the standard “positive screen” cutoff. Above this threshold, sensitivity for GAD diagnosis is ~89% and specificity ~82% (Spitzer et al., 2006).

What anxiety looks like clinically

Generalized anxiety disorder (DSM-5-TR diagnosis) requires:

1. Excessive worry about multiple topics, more days than not, for 6+ months
2. Difficult to control the worry
3. At least 3 of 6 physical symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance
4. Clinically significant distress or impairment
5. Not explained by substance use, medical condition, or other mental disorder

The GAD-7 captures the cognitive worry symptoms well but is less sensitive to physical symptoms.

Comorbidity is the rule, not the exception

In the large US population surveys, most people with GAD meet the criteria for at least one other mental disorder over their lifetime, and major depression is the most common partner by a distance. Panic disorder, social anxiety and alcohol problems come next. Chronic physical illness, pain especially, travels with it too.

This is why most clinicians give the GAD-7 alongside the PHQ-9 (depression screening). The two come from the same research group and are built to work together.

Why anxiety is dramatically under-treated

About 31% of US adults have an anxiety disorder at some point in their lives (NIMH, the National Institute of Mental Health). The ADAA (Anxiety and Depression Association of America) puts the share who get treatment at about 37%. Reasons:

• Stigma: anxiety gets read as weakness
• Cultural acceptance: “everyone has stress”
• Inadequate primary care screening
• Confusion between situational stress and clinical anxiety
• Lack of insurance coverage for therapy
• Long waits for therapy, often months
• Misdiagnosis (anxiety often presents as physical complaints: chest pain, GI issues, fatigue)

A positive GAD-7 score is the gateway to actual treatment for many people who didn’t realize their experience had a clinical name.

Treatment options for moderate-severe anxiety

Evidence-based first-line treatments:

1. Cognitive Behavioral Therapy (CBT): usually 8-12 sessions; a large effect, around 0.8, against waiting-list controls
2. SSRI medications: sertraline, escitalopram, paroxetine; an effect of roughly 0.3-0.4 against placebo
3. SNRI medications: venlafaxine, duloxetine; similar to the SSRIs
4. Combination CBT + medication: often used for severe cases
5. Mindfulness-based stress reduction (MBSR): in a 2023 JAMA Psychiatry trial (Hoge and colleagues, 276 adults with anxiety disorders), eight weeks of MBSR did as well as escitalopram

Don’t read the first two effect sizes as “therapy is twice as good as pills”. A waiting list is a much weaker comparison than a placebo pill, so the therapy figure starts with an advantage.

Less evidence-supported but commonly used:

• Benzodiazepines (Xanax, Ativan, Klonopin): fast-acting but addictive; usually not first-line for chronic anxiety
• Buspirone: non-addictive but slow onset, modest effect
• Beta blockers (propranolol): useful for performance anxiety specifically
• Cannabis/CBD: mixed evidence; can paradoxically worsen anxiety in many users
• Herbal remedies (kava, valerian, passionflower): minimal evidence

Self-help interventions that genuinely work

Even at mild anxiety levels (GAD-7 5-9), these have evidence behind them:

• Aerobic exercise: about 30 min, 3 times a week, with a moderate effect on anxiety in trials
• Reduce caffeine: 3 or more cups a day produces a racing heart and jitters that are hard to tell apart from anxiety
• Limit alcohol: alcohol withdrawal (even mild) causes anxiety rebound
• Sleep hygiene: chronic sleep deprivation precipitates anxiety
• Mindfulness apps (Calm, Headspace, Waking Up): 10 min/day for 8+ weeks
• Limit news/social media: particularly distressing content
• Strong social connections: isolation worsens anxiety

When anxiety becomes an emergency

Seek immediate help if:

• Thoughts of suicide or self-harm
• Panic attacks lasting >30 minutes or repeating
• Cannot function (work, school, basic self-care)
• Significant weight loss/gain from anxiety-driven changes in eating
• Substance use as a coping mechanism

In the US: 988 Suicide & Crisis Lifeline (call or text)
In the UK: Samaritans 116 123
In Australia: Lifeline 13 11 14

The “anxiety doesn’t have to be debilitating” perspective

For many people, anxiety is genuinely treatable. Pooled across 100 CBT trials for anxiety disorders, about half of people were in remission by the end of treatment (Springer, Levy and Tolin, 2018), and GAD did at least as well as the others. Medication trials in GAD report a response in roughly half of patients, against a placebo response that is high in its own right. Most people who get treatment improve, and most people with GAD never seek it.

If the GAD-7 score concerns you, the most useful single step is talking to a primary care physician or therapist. Even a 30-minute initial consultation can dramatically clarify whether what you’re experiencing fits clinical anxiety and what to do about it.

Tracking over time

The GAD-7 is most useful as a tracking tool, not a one-time snapshot. Many therapists administer it at every session to measure treatment progress. A drop from 15 to 7 over 12 weeks of CBT is a meaningful clinical improvement; a drop from 8 to 5 may not be.

Limitations of the GAD-7

• Self-report only, so vulnerable to underreporting (stigma) or overreporting (anxious about anxiety)
• Does not distinguish well between anxiety subtypes (GAD vs panic vs social vs OCD)
• 2-week window may miss episodic patterns
• Different cultural contexts can affect scoring (worry valence differs across cultures)
• Validated first in adults. Later studies support it for teenagers too, but a child’s score wants a clinician’s reading

Disclaimer (important)

This calculator is for educational and screening purposes only. It is not a diagnostic instrument, does not substitute for professional evaluation, and should not be used to self-diagnose or to determine treatment. If your score concerns you, please consult a healthcare provider. The GAD-7 was developed with an educational grant from Pfizer, and the form itself says “No permission required to reproduce, translate, display or distribute.”